Global Antibody Drug Conjugate (ADC) Forecast to 2028 - Next-Generation ADCs Spurring Growth Opportunities
22 août 2023 08h03 HE
|
Research and Markets
Dublin, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate (ADC) Growth Opportunities, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The report...
Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial
20 juil. 2023 11h45 HE
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today that the...
Global Cancer Antibody Drug Conjugates Market Outlook to 2029: Size, Drug Sales, Drug Dosage, Price, & Clinical Trials
16 juin 2023 06h28 HE
|
Research and Markets
Dublin, June 16, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugates Market Outlook 2029" report has been added to ResearchAndMarkets.com's offering.Global Cancer Antibody Drug...
Global Antibody Drug Conjugates Market to 2030: Rising Incidences of Cancer Worldwide Bolsters Growth
01 juin 2023 11h53 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.The Global Antibody Drug...
Global Antibody Drug Conjugates Market Size To Grow USD 23.9 Billion By 2032 | CAGR of 10.7%
30 mai 2023 14h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , May 30, 2023 (GLOBE NEWSWIRE) -- The Global Antibody Drug Conjugates Market Size is to grow from USD 8.6 Billion in 2022 to USD 23.9 billion by 2032, at a Compound Annual...
Antibody-drug Conjugates (ADC) Market Research Report 2023: Focus on Three ADC Components (Antibody, Linker, and Payload) and Clinical Trials that Display Potential
15 mai 2023 09h13 HE
|
Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Antibody-drug Conjugates: Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study covers several new...
Antibody-Drug Conjugates (ADCs) in Oncology Competitive Landscape Report 2023: Comprehensive Insights About 30+ Companies and 35+ Drugs
28 avr. 2023 09h23 HE
|
Research and Markets
Dublin, April 28, 2023 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates (ADCs) in Oncology- Competitive Landscape - 2023" report has been added to ResearchAndMarkets.com's offering.This...
Antibody Drug Conjugates Market Size & Share to Surpass $13.17 Billion by 2028 | Vantage Market Research
04 avr. 2023 11h07 HE
|
Vantage Market Research
WASHINGTON, DC, April 04, 2023 (GLOBE NEWSWIRE) -- The Global Antibody Drug Conjugates (ADCS) Market is valued at USD 4.24 Billion in 2021 and is projected to attain a value of USD 13.17 Billion by...
$13+ Billion Antibody Drug Conjugates Global Market to 2032 - North America was the Largest Region in 2022
13 mars 2023 12h23 HE
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Antibody Drug Conjugates Contract Market Size to Hit US$ 38.8 Billion by 2032, Growing at a CAGR of 15.5%: Fact.MR
30 janv. 2023 13h00 HE
|
FACT.MR
Rockville, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Fact.MR – A Market Research and Competitive Intelligence Provider: The Antibody Drug Conjugates Contract industry revenues were valued at US$ 8.1Bn in...